Fibroblast, a digital health platform that empowers providers with an easy-to-use, end-to-end automated referral tool, was founded in 2010 by a lawyer and a gastroenterologist with a passion for healthcare reform. A decade later, the longtime MATTER startup was acquired by EHR powerhouse Cerner.
At this event, Fibroblast Co-founder and CEO Scott Vold, Cerner SVP Kim Hlobik and MATTER CEO Steven Collens discussed the ups and downs of Scott’s entrepreneurial journey, Cerner’s collaboration and acquisition strategy and their advice for startups looking to sell to major EHRs and what is coming for digital health in 2021.
